Want to see TSE:AIDR full AI Analyst Report?
Top Page
Rocket Doctor AI
(AIDR)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.59
▼(-0.85% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily held back by weak financial performance driven by large operating losses and continued cash burn, despite strong revenue growth and high gross margin. Technicals also weigh on the rating as the stock trades below major moving averages. Valuation is difficult to assess with a negative P/E and no dividend yield provided.
Positive Factors
High Gross Margin
Sustained ~89% gross margin indicates strong unit economics for the platform and AI-enabled services. High contribution margins provide structural leverage as revenue scales, increasing the potential to cover fixed R&D and SG&A and improve profitability over a multi-quarter horizon.
Negative Factors
Large Operating Losses
Significant recurring operating losses far exceed current revenue, reflecting a cost base not yet matched to scale. This structural deficit must be closed via sustained revenue scale, material cost reductions, or external capital, or else earnings power will remain impaired over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
High Gross Margin
Sustained ~89% gross margin indicates strong unit economics for the platform and AI-enabled services. High contribution margins provide structural leverage as revenue scales, increasing the potential to cover fixed R&D and SG&A and improve profitability over a multi-quarter horizon.
Read all positive factors
Rocket Doctor AI (AIDR) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$54.26M
Dividend YieldN/A
Average Volume (3M)175.17K
Price to Earnings (P/E)―
Beta (1Y)0.82
Revenue Growth22432.50%
EPS Growth-22.03%
CountryCA
Employees3
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.24
Shares Outstanding96,894,780
10 Day Avg. Volume215,584
30 Day Avg. Volume175,170
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)15.03
Price to Sales (P/S)30.35
P/FCF Ratio-8.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.55Price Target Upside162.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.07
Revenue Forecast (FY)C$4.79M
Rocket Doctor AI Business Overview & Revenue Model
Company Description
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effecti...
How the Company Makes Money
null...
Rocket Doctor AI Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
58
Neutral
Cash Flow
24
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.74M | 10.99K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -6.03M | 10.99K | 0.00 | -377.28K | -656.40K |
| EBITDA | -14.03M | -7.52M | -2.33M | 0.00 | 0.00 |
| Net Income | -15.69M | -7.55M | -3.72M | -3.80M | -13.86M |
Balance Sheet | |||||
| Total Assets | 10.64M | 1.28M | 739.31K | 13.67K | 942.51K |
| Cash, Cash Equivalents and Short-Term Investments | 641.78K | 1.23M | 715.53K | 2.50K | 916.75K |
| Total Debt | 415.64K | 152.00K | 584.79K | 566.28K | 0.00 |
| Total Liabilities | 7.13M | 486.43K | 1.48M | 2.20M | 832.62K |
| Stockholders Equity | 3.51M | 792.77K | -738.05K | -2.19M | 109.90K |
Cash Flow | |||||
| Free Cash Flow | -6.56M | -4.44M | -740.08K | -1.46M | -6.29M |
| Operating Cash Flow | -6.55M | -4.44M | -740.08K | -1.46M | -6.29M |
| Investing Cash Flow | -1.35M | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.34M | 4.97M | 1.45M | 540.62K | 6.94M |
Rocket Doctor AI Technical Analysis
Negative
0.59
Price Trends
0.61
Negative
0.61
Negative
0.69
Negative
Market Momentum
-0.02
Positive
36.54
Neutral
18.06
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AIDR, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.61, below the 50-day MA of 0.61, and below the 200-day MA of 0.69, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 36.54 is Neutral, neither overbought nor oversold. The STOCH value of 18.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AIDR.
Rocket Doctor AI Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$474.11M | 60.60 | 2.98% | ― | 58.90% | 124.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | C$54.26M | -2.33 | -207.53% | ― | 22432.50% | -22.03% | |
45 Neutral | C$31.91M | -6.30 | 9999.00% | ― | -36.92% | 13.03% | |
45 Neutral | C$2.89M | -21.21 | -34.06% | ― | -100.00% | 42.39% | |
44 Neutral | C$4.60M | -3.43 | 527.45% | ― | ― | -21.65% | |
42 Neutral | C$6.91M | -2.00 | 6239.15% | ― | ― | 68.00% |
* Healthcare Sector Average
TSE:AIDR
Rocket Doctor AI
0.56
0.16
40.00%
TSE:ADK
Diagnos
0.26
0.04
18.18%
TSE:VHI
Vitalhub
7.29
-4.96
-40.49%
TSE:NDAT
nDatalyze Corp
0.07
0.06
366.67%
TSE:UDOC
UniDoc Health Corp
0.08
-0.13
-61.90%
TSE:DMED
DiagnaMed Holdings Corp.
0.04
>-0.01
-12.50%
Rocket Doctor AI Corporate Events
Business Operations and Strategy
Rocket Doctor AI Expands Maryland Reach With Major Insurer Deal
Positive
Apr 14, 2026
Rocket Doctor AI has expanded its in-network reach in Maryland through a new agreement with the state entity of a major national health insurer, adding access for roughly 2 million additional members across commercial, Medicaid managed care, and M...
Business Operations and StrategyExecutive/Board Changes
Rocket Doctor AI Expands Into Maryland, Names New Medical Lead to Drive U.S. Growth
Positive
Apr 8, 2026
Rocket Doctor AI has launched patient care operations in Maryland through its wholly owned digital health platform, following the establishment of in-network coverage with Medicaid and Medicare in the state. The company is initially delivering car...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.